Atlas Trials

Superparamagnetic Iron Oxide for Sentinel Lymph Node Localization in Patients With Cutaneous Melanoma, a Randomized Phase III Multi-center Non- Inferiority Trial: MagMen-II

Clinical trial NCT07552597 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07552597
Sponsor
Vastra Gotaland Region
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Melanoma (Skin Cancer)
Start date
2026-05-04
Primary completion
2029-12-31
Enrollment
254

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.